Nantahala Capital Management LLC Cuts Stock Holdings in Assertio Holdings, Inc. (NASDAQ:ASRT)

Nantahala Capital Management LLC lessened its stake in Assertio Holdings, Inc. (NASDAQ:ASRT - Free Report) by 8.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 8,148,336 shares of the company's stock after selling 800,000 shares during the period. Nantahala Capital Management LLC owned about 8.53% of Assertio worth $7,098,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in ASRT. Geode Capital Management LLC boosted its holdings in Assertio by 2.0% in the fourth quarter. Geode Capital Management LLC now owns 1,095,911 shares of the company's stock worth $955,000 after acquiring an additional 21,059 shares in the last quarter. Empowered Funds LLC lifted its holdings in shares of Assertio by 5.4% in the fourth quarter. Empowered Funds LLC now owns 455,282 shares of the company's stock valued at $397,000 after purchasing an additional 23,369 shares in the last quarter. CM Management LLC lifted its holdings in shares of Assertio by 23.1% in the fourth quarter. CM Management LLC now owns 400,000 shares of the company's stock valued at $348,000 after purchasing an additional 75,000 shares in the last quarter. Northern Trust Corp lifted its holdings in shares of Assertio by 21.3% in the fourth quarter. Northern Trust Corp now owns 227,217 shares of the company's stock valued at $198,000 after purchasing an additional 39,906 shares in the last quarter. Finally, Palumbo Wealth Management LLC lifted its holdings in shares of Assertio by 10.6% in the fourth quarter. Palumbo Wealth Management LLC now owns 205,598 shares of the company's stock valued at $179,000 after purchasing an additional 19,637 shares in the last quarter. Institutional investors and hedge funds own 48.96% of the company's stock.

Assertio Stock Performance

NASDAQ:ASRT traded up $0.00 during trading hours on Thursday, reaching $0.65. The stock had a trading volume of 310,570 shares, compared to its average volume of 711,847. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.57 and a current ratio of 2.01. The stock has a 50 day simple moving average of $0.69 and a 200 day simple moving average of $0.84. Assertio Holdings, Inc. has a 12-month low of $0.51 and a 12-month high of $1.80. The stock has a market cap of $62.26 million, a P/E ratio of -0.89, a price-to-earnings-growth ratio of 3.25 and a beta of 0.56.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. StockNews.com upgraded Assertio from a "hold" rating to a "buy" rating in a report on Monday, April 14th. HC Wainwright decreased their price target on Assertio from $4.00 to $3.50 and set a "buy" rating for the company in a research report on Wednesday, March 19th. Finally, Industrial Alliance Securities set a $1.75 price target on Assertio in a research report on Friday, March 14th.

Assertio Profile

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.